Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 5101-5150 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06003244
High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)
NAActive, not recruiting
24 participants
Started: Sep 23, 2023 · Completed: Dec 31, 2023
3 conditions1 sponsor1 location
NCT06092424
High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)
NAActive, not recruiting
36 participants
Started: Sep 23, 2023 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05889689
Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters
NAActive, not recruiting
2,250 participants
Started: Sep 23, 2023 · Completed: Apr 30, 2026
5 conditions3 sponsors1 location
NCT05992649
The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject
NAActive, not recruiting
12 participants
Started: Sep 23, 2023 · Completed: Jul 4, 2024
1 condition2 sponsors1 location
NCT05923866
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
PHASE2Active, not recruiting
92 participants
Started: Sep 22, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor35 locations
NCT05667974
A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried
PHASE3Active, not recruiting
4,500 participants
Started: Sep 22, 2023 · Completed: Feb 21, 2025
2 conditions1 sponsor7 locations
NCT06098040
Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients
NAActive, not recruiting
42 participants
Started: Sep 22, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05683834
Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
PHASE1/PHASE2Active, not recruiting
25 participants
Started: Sep 22, 2023 · Completed: Apr 1, 2027
3 conditions1 sponsor2 locations
NCT06072417
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)
NAActive, not recruiting
24 participants
Started: Sep 22, 2023 · Completed: Dec 31, 2023
3 conditions1 sponsor1 location
NCT06040086
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
PHASE3Active, not recruiting
1,454 participants
Started: Sep 22, 2023 · Completed: May 22, 2026
1 condition1 sponsor385 locations
NCT06477315
Mid- and Long-term Evaluation of the Results of Patients Undergoing Spinal Cord Stimulation With Microfractures + BST CarGel in the Treatment of Patellofemoral Chondral Lesions of the Knee
N/AActive, not recruiting
15 participants
Started: Sep 22, 2023 · Completed: Jul 31, 2029
2 conditions1 sponsor1 location
NCT05816122
MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect
NAActive, not recruiting
336 participants
Started: Sep 22, 2023 · Completed: May 31, 2027
1 condition1 sponsor34 locations
NCT05988203
A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines
PHASE1/PHASE2Active, not recruiting
96 participants
Started: Sep 21, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor8 locations
NCT05849610
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
PHASE2Active, not recruiting
30 participants
Started: Sep 21, 2023 · Completed: Jul 31, 2029
1 condition2 sponsors10 locations
NCT06037252
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
PHASE2Active, not recruiting
350 participants
Started: Sep 21, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor40 locations
NCT05822752
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)
PHASE2Active, not recruiting
130 participants
Started: Sep 21, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor59 locations
NCT06416072
Alzheimer's Plasma Extension
N/AActive, not recruiting
1,000 participants
Started: Sep 21, 2023 · Completed: Jun 30, 2028
2 conditions4 sponsors56 locations
NCT05529654
IMpella-Protected cArdiaC Surgery Trial (IMPACT)
NAActive, not recruiting
100 participants
Started: Sep 21, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor20 locations
NCT05926414
To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus
N/AActive, not recruiting
15,000 participants
Started: Sep 21, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05972473
A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
PHASE3Active, not recruiting
600 participants
Started: Sep 21, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05505552
Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis:
NAActive, not recruiting
37 participants
Started: Sep 20, 2023 · Completed: Dec 31, 2026
1 condition4 sponsors3 locations
NCT06045546
A (5-5-5-8) Technique for Laparoscopic Cholecystectomy
NAActive, not recruiting
524 participants
Started: Sep 20, 2023 · Completed: Sep 20, 2026
3 conditions2 sponsors1 location
NCT06054061
"Evaluation the Efficacy Think and Cope Positively Program"
NAActive, not recruiting
449 participants
Started: Sep 20, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06621043
Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)
PHASE1/PHASE2Active, not recruiting
14 participants
Started: Sep 20, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06055413
Home-based Optimization of Mechanical Ventilation in Children
NAActive, not recruiting
50 participants
Started: Sep 20, 2023 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT06584396
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study
N/AActive, not recruiting
140 participants
Started: Sep 20, 2023 · Completed: Aug 30, 2027
1 condition2 sponsors1 location
NCT05905835
Treatment of PAF With the Synaptic System
NAActive, not recruiting
128 participants
Started: Sep 20, 2023 · Completed: Dec 5, 2025
1 condition1 sponsor10 locations
NCT05864612
Tools for Anxiety and Depression Screening in Epilepsy
NAActive, not recruiting
1,322 participants
Started: Sep 20, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06277518
System for Postoperative Admission to ICU for Patients With Digestive System Malignancy
N/AActive, not recruiting
2,000 participants
Started: Sep 20, 2023 · Completed: Jun 20, 2026
1 condition1 sponsor1 location
NCT06047548
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
PHASE3Active, not recruiting
400 participants
Started: Sep 20, 2023 · Completed: May 31, 2026
2 conditions1 sponsor20 locations
NCT06062290
Does Electromyography Improve Precision and Reliability of Neuromuscular Monitoring in Paediatric Patients
N/AActive, not recruiting
64 participants
Started: Sep 20, 2023 · Completed: Dec 10, 2024
2 conditions1 sponsor1 location
NCT05535218
Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer
PHASE2Active, not recruiting
48 participants
Started: Sep 20, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06916377
The Economics of Domestic Violence: Evidence From Bangladesh
NAActive, not recruiting
440 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2025
2 conditions8 sponsors1 location
NCT06062537
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
N/AActive, not recruiting
200 participants
Started: Sep 19, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors31 locations
NCT05994300
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
NAActive, not recruiting
30 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06272253
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
EARLY_PHASE1Active, not recruiting
250 participants
Started: Sep 19, 2023 · Completed: Jul 19, 2024
2 conditions4 sponsors1 location
NCT05854381
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
PHASE1Active, not recruiting
95 participants
Started: Sep 19, 2023 · Completed: Nov 30, 2027
1 condition2 sponsors10 locations
NCT06053827
Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
N/AActive, not recruiting
500 participants
Started: Sep 19, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05864560
Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up
N/AActive, not recruiting
164 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor7 locations
NCT05796453
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
NAActive, not recruiting
470 participants
Started: Sep 19, 2023 · Completed: Jun 30, 2028
3 conditions1 sponsor7 locations
NCT05736484
Randomized Clinical Trial to Improve Mobility After Hospitalization
NAActive, not recruiting
350 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT06714188
Application of Personalized Palliative Care in Patients With Newly Diagnosed Idiopathic Pulmonary Fibrosis
N/AActive, not recruiting
30 participants
Started: Sep 19, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05910502
Project AFECT (Autism Family Empowerment Coaching and Training Program)
NAActive, not recruiting
200 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2025
7 conditions1 sponsor2 locations
NCT06051968
Effects of an Online Hearing Support for First-time Hearing Aid Users
NAActive, not recruiting
100 participants
Started: Sep 18, 2023 · Completed: Nov 30, 2026
7 conditions2 sponsors1 location
NCT06026514
Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
PHASE1Active, not recruiting
27 participants
Started: Sep 18, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT06024083
Skills Video Intervention for Chinese/Chinese Americans
NAActive, not recruiting
91 participants
Started: Sep 18, 2023 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT06115343
Conscious Awareness Practice in Adolescents
NAActive, not recruiting
60 participants
Started: Sep 18, 2023 · Completed: Nov 20, 2023
1 condition1 sponsor1 location
NCT06001801
The Inspiring Action to Prevent Diabetes Intervention
NAActive, not recruiting
142 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06064071
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
NAActive, not recruiting
100 participants
Started: Sep 18, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor3 locations
NCT05534477
Verily Clinical Study Watch Analytical Validation Study
N/AActive, not recruiting
100 participants
Started: Sep 18, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location